Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study (Q33319304)

25 July 2017

title

Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study (English)

1 reference

25 July 2017

0 references

María T Milanés-Virelles

1 reference

25 July 2017

Idrian García-García

1 reference

25 July 2017

Yamilet Santos-Herrera

1 reference

25 July 2017

Magalys Valdés-Quintana

1 reference

25 July 2017

Carmen M Valenzuela-Silva

1 reference

25 July 2017

Gaspar Jiménez-Madrigal

1 reference

25 July 2017

Thelvia I Ramos-Gómez

1 reference

25 July 2017

Iraldo Bello-Rivero

1 reference

25 July 2017

Norma Fernández-Olivera

1 reference

25 July 2017

Reinaldo B Sánchez-de la Osa

1 reference

25 July 2017

Carmen Rodríguez-Acosta

1 reference

25 July 2017

Lidia González-Méndez

1 reference

25 July 2017

Gregorio Martínez-Sánchez

1 reference

25 July 2017

Pedro A López-Saura

1 reference

25 July 2017

MACGAM Study Group

1 reference

25 July 2017

publication date

11 February 2008

1 reference

25 July 2017

published in

BMC Infectious Diseases

1 reference

25 July 2017

1 reference

25 July 2017

1 reference

Therapeutic efficacy of ozone in patients with diabetic foot.

25 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Mycobacterium avium complex pulmonary disease in patients without HIV infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Mycobacterium tuberculosis and Mycobacterium avium modify the composition of the phagosomal membrane in infected macrophages by selective depletion of cell surface-derived glycoconjugates

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Six-month therapy with aerosolized interferon-gamma for refractory multidrug-resistant pulmonary tuberculosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Recent advances in the analysis of oxidized proteins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Anti-inflammatory properties of pro-inflammatory interferon-gamma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Oxidative stress and gene expression in sepsis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Host susceptibility factors in mycobacterial infection. Genetics and body morphotype

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Immunotherapy of mycobacterial infections

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Macrophages are a significant source of type 1 cytokines during mycobacterial infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Therapy of mycobacterial infections

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Use of adjunctive treatment with interferon-gamma in an immunocompromised patient who had refractory multidrug-resistant tuberculosis of the brain

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Inflammatory response following intranasal infection with Mycobacterium avium complex: role of T-cell subsets and gamma interferon

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Clinical toxicity of the interferons.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Possible role of regional superoxide dismutase activity and lipid peroxide levels in cadmium neurotoxicity: in vivo and in vitro studies in growing rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Infection with Mycobacterium avium complex in patients without predisposing conditions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency sy

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-17

Inhaled IFN-gamma for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-gamma deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-17

Clinical features of dominant and recessive interferon γ receptor 1 deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-17

Infection multifocale à Mycobacterium intracellulare: premier cas de déficit partiel dominant du récepteur de l'interféron gamma en milieu tropical français

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-17

Aerosolized interferon gamma for Mycobacterium avium-complex lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-17

Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-17

Release of biologically active TGF-beta1 by alveolar epithelial cells results in pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-17

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-17

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-17

Disseminated Mycobacterium avium infection in a 20-year-old female with partial recessive IFNgammaR1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-17

Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-17

Export of recombinant Mycobacterium tuberculosis superoxide dismutase is dependent upon both information in the protein and mycobacterial export machinery. A model for studying export of leaderless proteins by pathogenic mycobacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-17

Mycobacterium avium complex promotes recruitment of monocyte hosts for HIV-1 and bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-17

TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275277

Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis

31 October 2018

1 reference

12 December 2020

Regulation of collagen synthesis and mRNA expression in normal and hypertrophic scar fibroblasts in vitro by interferon-gamma

1 reference

12 December 2020

Increased advanced oxidation protein products in Behçet's disease: a new activity marker?

1 reference

12 December 2020

Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy

1 reference

12 December 2020

Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal

1 reference

12 December 2020

Interferon-gamma treatment for Mycobacterium avium-intracellular complex bacillemia in patients with AIDS

1 reference

12 December 2020

Peroxidation potential and antioxidant activity of serum in patients with diabetes mellitus and myocard infarction

1 reference

12 December 2020

Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production

1 reference

12 December 2020

[Anti-fibrotic effects of interferons. Mechanisms of action and therapeutic prospects]

1 reference

12 December 2020

Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure

1 reference

12 December 2020

Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2334-8-17

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference